LUCHETTI GENTILONI, Michele Maria
 Distribuzione geografica
Continente #
NA - Nord America 4.318
EU - Europa 2.534
AS - Asia 971
SA - Sud America 176
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 8.107
Nazione #
US - Stati Uniti d'America 4.297
UA - Ucraina 444
IT - Italia 422
SE - Svezia 368
RU - Federazione Russa 318
SG - Singapore 317
IE - Irlanda 268
DE - Germania 237
CN - Cina 193
HK - Hong Kong 171
DK - Danimarca 163
BR - Brasile 161
TR - Turchia 148
FI - Finlandia 91
GB - Regno Unito 87
KR - Corea 87
FR - Francia 76
CI - Costa d'Avorio 50
MA - Marocco 44
IN - India 26
BE - Belgio 19
AT - Austria 16
CA - Canada 13
JP - Giappone 8
NL - Olanda 7
CO - Colombia 6
IQ - Iraq 5
PL - Polonia 5
EU - Europa 4
AR - Argentina 3
AU - Australia 3
LT - Lituania 3
MX - Messico 3
MY - Malesia 3
RS - Serbia 3
AZ - Azerbaigian 2
ES - Italia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
UY - Uruguay 2
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.107
Città #
Chandler 712
Jacksonville 474
Fairfield 306
Ashburn 278
Dublin 263
Des Moines 262
Boardman 253
Wilmington 184
Hong Kong 171
Singapore 148
Woodbridge 147
New York 127
Ann Arbor 126
Seattle 117
Houston 109
Lawrence 107
Princeton 107
San Mateo 103
Centro 88
Cambridge 75
Moscow 73
The Dalles 64
Abidjan 50
San Diego 46
Redmond 42
Turin 36
Beijing 33
Ancona 24
London 24
Los Angeles 20
Guangzhou 18
Norwalk 18
Washington 18
Brussels 17
Pune 17
Dallas 16
Marche 16
Porto 16
Wuhan 15
Helsinki 13
Shanghai 13
Rome 12
Milan 10
São Paulo 10
Munich 8
Vienna 8
Nuremberg 7
Amandola 6
Belo Horizonte 6
Jesi 6
Jinhua 6
Ostra 6
Rio de Janeiro 6
Comunanza 5
Goiânia 5
Kilburn 5
San Benedetto Del Tronto 5
Sassoferrato 5
Toronto 5
Auburn Hills 4
Bologna 4
Falls Church 4
Fuzhou 4
Istanbul 4
Izmir 4
Montréal 4
Ottawa 4
Redwood City 4
San Giorgio A Cremano 4
Shenzhen 4
Southwark 4
Turku 4
Atella 3
Belgrade 3
Brasília 3
Campinas 3
Castelfidardo 3
Chennai 3
Corridonia 3
Dearborn 3
Hangzhou 3
Jiaxing 3
New Bedfont 3
Perugia 3
Petaling Jaya 3
Rosora 3
Santa Clara 3
Seoul 3
Zhengzhou 3
Acton 2
Ankara 2
Anápolis 2
Ascoli Piceno 2
Baku 2
Betim 2
Borås 2
Brisbane 2
Caraguatatuba 2
Casoria 2
Civitanova Marche 2
Totale 4.992
Nome #
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 133
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 132
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 124
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 121
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 118
Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma 114
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 114
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 108
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 105
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 103
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 103
6. Tenoxicam and ketoprofen level monitoring with high-performance liquid chromatography in patients affected by rheumatoid arthritis 101
Low number of complement C3B/C4B receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis 101
A new HLA-DRB1*11 allele, DRB1*1144, identified by cloning and sequencing 100
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 96
Certolizumab pegol for the treatment of psoriasis 96
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 95
Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile 94
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 94
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 94
FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth 94
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 94
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 93
c-MYB transactivates the alpha 2(I) collagen gene. 91
5-methylcytosine content of DNA in blood and synovial mononuclear cells and in synovial tissue from patients affected by rheumatic autoimmune disease. 90
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 90
Skin Involvement in SARS-CoV-2 Infection: Case Series 90
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 89
MR imaging of rheumatoid hand lesions: comparison with conventional radiology in 31 patients 89
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 88
Dissociation between p93-B-myb and p75-c-myb expression during proliferation and differentiation of human myeloid cells lines 88
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 88
Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis. 87
21. The Myb oncogene family of transcription factors: potent regulators of hematopoietic cells proliferation and differentiation. 86
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 86
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 85
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 85
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 85
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 84
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 84
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 83
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 83
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 82
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 82
Effect of high-doses intravenous immunoglobulin in rheumatoid arthritis 81
Biologics in inflammatory and immunomediated arthritis 81
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 79
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 79
C-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation 79
Preliminary validation of the Simplified Psoriatic Arthritis Radiographic Score (SPARS) 79
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 78
c-myb, but not B-myb, upregulates alfa-1(I) and alfa-2(I) collagen gene expression in fibroblasts 77
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 77
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 77
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 76
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 76
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 74
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 74
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 73
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 72
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 71
Stimulatory autoantibodies against PDGF receptors in Scleroderma 69
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 68
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 68
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 67
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 67
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 66
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 65
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 64
Collagen loss and impaired wound healing is associated with c-Myb deficiency. 64
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 64
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 64
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 63
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 62
Dolore Articolare Acuto 62
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 62
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 60
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 57
Widespread painful nodules in a patient with rheumatoid arthritis 57
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of free radical generation through the NADPH oxidase complex pathway 56
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 56
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 56
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 56
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 55
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 54
Reversible transdifferentiation of secretory epithelial cells into adipocytes in the mammary gland 54
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 54
High risk low-grade lymphoma: Molecular remission after intensive sequential chemotherapy. 53
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 53
Therapeutic approach with IVIG in patients affected by connective tissue disease 53
HLA-B*4904, a new allele identified in two unrelated individuals from the same Italian region. 53
Reply 53
Expression and production of the long pentraxin PTX-3 in rheumatoid arthritis 52
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 51
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 51
Vitamin d signaling in gastro-rheumatology: From immuno-modulation to potential clinical applications 49
Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion 48
Intestinal sclerostin/serotonin axis is modulated by dysbiosis and regulates ilc3 expansion in as patients 48
Expression of C-MYB and B-MYB oncogenes on myelofibrotic marrow fibroblasts 46
Characterization of a novel allele HLA-CW*160102 45
Totale 7.790
Categoria #
all - tutte 44.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 0 0 0 0 0 0 0 30 122
2020/20211.467 90 134 216 33 172 89 128 102 150 133 147 73
2021/2022856 52 178 32 47 13 56 30 49 50 70 107 172
2022/20231.956 164 216 140 187 137 439 3 101 403 14 114 38
2023/2024924 162 25 49 129 135 215 36 37 6 23 8 99
2024/20251.554 202 186 92 24 105 68 245 59 400 98 75 0
Totale 8.325